Latest Ratings for HALO
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2021 | Wells Fargo | Maintains | Overweight | |
| Nov 2021 | JMP Securities | Maintains | Market Outperform | |
| Nov 2021 | SVB Leerink | Maintains | Outperform |
Assessing Halozyme Therapeutics: Insights From 9 Financial Analysts
